Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse-type gastric carcinoma-initiating cells is inhibited by TGF-β

Journal of Pathology

Volumn 228, Issue 3, 2012, Pages 391-404

  Katsuno, Yoko ^a   Ehata, Shogo ^a   Yashiro, Masakazu ^b   Yanagihara, Kazuyoshi ^c   Hirakawa, Kosei ^b   Miyazono, Kohei ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c YASUDA WOMEN'S UNIVERSITY   (Japan)

Author keywords

ALDH1; cancer initiating cells; diffuse type gastric cancer; REG4; TGF

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 1; REG4 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR MARKER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER TISSUE; CARCINOGENICITY; CARCINOMA CELL; CELL HETEROGENEITY; CELL ISOLATION; CELL POPULATION; CELL RENEWAL; CELL SIZE; COLONY FORMING UNIT; CONTROLLED STUDY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; STOMACH CARCINOMA; UPREGULATION;

ADENOCARCINOMA; ANIMALS; CARCINOMA, SIGNET RING CELL; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOENZYMES; LECTINS, C-TYPE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASTIC STEM CELLS; RETINAL DEHYDROGENASE; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84867575420     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4020     Document Type: Article

References (51)

1. Visvader JE, Lindeman GJ,. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nature Rev Cancer 2008; 8: 755-768.
2. Duester G,. Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid. Eur J Biochem 2000; 267: 4315-4324.
3. Ginestier C, Hur MH, Charafe-Jauffret E, et al., ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007; 1: 555-567.
4. Sullivan JP, Spinola M, Dodge M, et al., Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling. Cancer Res 2010; 70: 9937-9948.
5. Huang EH, Hynes MJ, Zhang T, et al., Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 2009; 69: 3382-3389.
6. Rasheed ZA, Yang J, Wang Q, et al., Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma. J Natl Cancer Inst 2010; 102: 340-351.
7. Jones RJ, Barber JP, Vala MS, et al., Assessment of aldehyde dehydrogenase in viable cells. Blood 1995; 85: 2742-2746.
8. Corti S, Locatelli F, Papadimitriou D, et al., Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity. Stem Cells 2006; 24: 975-985.
9. Ma I, Allan AL,. The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Rev 2011; 7: 292-306.
10. Charafe-Jauffret E, Ginestier C, Iovino F, et al., Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin Cancer Res 2010; 16: 45-55.
11. Li T, Su Y, Mei Y, et al., ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome. Lab Invest 2010; 90: 234-244.
12. Jiang F, Qiu Q, Khanna A, et al., Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res 2009; 7: 330-338.
13. Hohenberger P, Gretschel S,. Gastric cancer. Lancet 2003; 362: 305-315.
14. Crew KD, Neugut AI,. Epidemiology of gastric cancer. World J Gastroenterol 2006; 12: 354-362.
15. Yashiro M, Chung YS, Sowa M,. Role of orthotopic fibroblasts in the development of scirrhous gastric carcinoma. Jpn J Cancer Res 1994; 85: 883-886.
16. Yashiro M, Chung YS, Nishimura S, et al., Establishment of two new scirrhous gastric cancer cell lines: analysis of factors associated with disseminated metastasis. Br J Cancer 1995; 72: 1200-1210.
17. Fujihara T, Sawada T, Hirakawa K, et al., Establishment of lymph node metastatic model for human gastric cancer in nude mice and analysis of factors associated with metastasis. Clin Exp Metastasis 1998; 16: 389-398.
18. Yashiro M, Chung YS, Nishimura S, et al., Peritoneal metastatic model for human scirrhous gastric carcinoma in nude mice. Clin Exp Metastasis 1996; 14: 43-54.
19. Yanagihara K, Seyama T, Tsumuraya M, et al., Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene. Cancer Res 1991; 51: 381-386.
20. Yanagihara K, Kamada N, Tsumuraya M, et al., Establishment and characterization of a human gastric scirrhous carcinoma cell line in serum-free chemically defined medium. Int J Cancer 1993; 54: 200-207.
21. Yashiro M, Yasuda K, Nishii T, et al., Epigenetic regulation of the embryonic oncogene ERas in gastric cancer cells. Int J Oncol 2009; 35: 997-1003.
22. Kato Y, Yashiro M, Noda S, et al., Establishment and characterization of a new hypoxia-resistant cancer cell line, OCUM-12/Hypo, derived from a scirrhous gastric carcinoma. Br J Cancer 2010; 102: 898-907.
23. Nagano Y, Koinuma D, Miyazawa K, et al., Context-dependent regulation of the expression of c-Ski protein by Arkadia in human cancer cells. J Biochem 2010; 147: 545-554.
24. Ehata S, Hanyu A, Hayashi M, et al., Transforming growth factor-beta promotes survival of mammary carcinoma cells through induction of antiapoptotic transcription factor DEC1. Cancer Res 2007; 67: 9694-9703.
25. Ehata S, Johansson E, Katayama R, et al., Transforming growth factor-beta decreases the cancer-initiating cell population within diffuse-type gastric carcinoma cells. Oncogene 2011; 30: 1693-1705.
26. Hoshino Y, Katsuno Y, Ehata S, et al., Autocrine TGF-beta protects breast cancer cells from apoptosis through reduction of BH3-only protein, Bim. J Biochem 2011; 149: 55-65.
27. Katayama K, Wada K, Miyoshi H, et al., RNA interfering approach for clarifying the PPARgamma pathway using lentiviral vector expressing short hairpin RNA. FEBS Lett 2004; 560: 178-182.
28. Katsuno Y, Hanyu A, Kanda H, et al., Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway. Oncogene 2008; 27: 6322-6333.
29. Oue N, Mitani Y, Aung PP, et al., Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma. J Pathol 2005; 207: 185-198.
30. Violette S, Festor E, Pandrea-Vasile I, et al., Reg IV, a new member of the regenerating gene family, is overexpressed in colorectal carcinomas. Int J Cancer 2003; 103: 185-193.
31. Zhang Y, Lai M, Lv B, et al., Overexpression of Reg IV in colorectal adenoma. Cancer Lett 2003; 200: 69-76.
32. Legoffic A, Calvo E, Cano C, et al., The reg4 gene, amplified in the early stages of pancreatic cancer development, is a promising therapeutic target. PLoS One 2009; 4: e7495.
33. Ohara S, Oue N, Matsubara A, et al., Reg IV is an independent prognostic factor for relapse in patients with clinically localized prostate cancer. Cancer Sci 2008; 99: 1570-1577.
34. Bishnupuri KS, Luo Q, Murmu N, et al., Reg IV activates the epidermal growth factor receptor/Akt/AP-1 signaling pathway in colon adenocarcinomas. Gastroenterology 2006; 130: 137-149.
35. Mizoi T, Ohtani H, Miyazono K, et al., Immunoelectron microscopic localization of transforming growth factor beta 1 and latent transforming growth factor beta 1 binding protein in human gastrointestinal carcinomas: qualitative difference between cancer cells and stromal cells. Cancer Res 1993; 53: 183-190.
36. Komuro A, Yashiro M, Iwata C, et al., Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor-beta signaling. J Natl Cancer Inst 2009; 101: 592-604.
37. Kiyono K, Suzuki HI, Morishita Y, et al., c-Ski overexpression promotes tumor growth and angiogenesis through inhibition of transforming growth factor-beta signaling in diffuse-type gastric carcinoma. Cancer Sci 2009; 100: 1809-1816.
38. Miyazawa K, Shinozaki M, Hara T, et al., Two major Smad pathways in TGF-beta superfamily signalling. Genes Cells 2002; 7: 1191-1204.
39. Su Y, Qiu Q, Zhang X, et al., Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer. Cancer Epidemiol Biomarkers Prev 2010; 19: 327-337.
40. Hartupee JC, Zhang H, Bonaldo MF, et al., Isolation and characterization of a cDNA encoding a novel member of the human regenerating protein family: Reg IV. Biochim Biophys Acta 2001; 1518: 287-293.
41. Oue N, Hamai Y, Mitani Y, et al., Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Res 2004; 64: 2397-2405.
42. Mitani Y, Oue N, Matsumura S, et al., Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy. Oncogene 2007; 26: 4383-4393.
43. Bishnupuri KS, Luo Q, Sainathan SK, et al., Reg IV regulates normal intestinal and colorectal cancer cell susceptibility to radiation-induced apoptosis. Gastroenterology 2010; 138:616-626, 626.e1-e2.
44. Tao HQ, He XJ, Ma YY, et al., Evaluation of REG4 for early diagnosis and prognosis of gastric cancer. Hum Pathol 2011; 42: 1401-1409.
45. Watabe T, Miyazono K,. Roles of TGF-beta family signaling in stem cell renewal and differentiation. Cell Res 2009; 19: 103-115.
46. Mani SA, Guo W, Liao MJ, et al., The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-715.
47. Scheel C, Eaton EN, Li SH, et al., Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell 2011; 145: 926-940.
48. Ikushima H, Todo T, Ino Y, et al., Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. Cell Stem Cell 2009; 5: 504-514.
49. Penuelas S, Anido J, Prieto-Sanchez RM, et al., TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell 2009; 15: 315-327.
50. Naka K, Hoshii T, Muraguchi T, et al., TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature 2010; 463: 676-680.
51. Tang B, Yoo N, Vu M, et al., Transforming growth factor-beta can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft model. Cancer Res 2007; 67: 8643-8652.